• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENCORE MEDICAL L.P. EXPRT REVISION HIP; EXPRT REVISION HIP, STANDARD OFFSET PROXIMAL BODY, 75MM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENCORE MEDICAL L.P. EXPRT REVISION HIP; EXPRT REVISION HIP, STANDARD OFFSET PROXIMAL BODY, 75MM Back to Search Results
Catalog Number 495-00-075
Health Effect - Clinical Code No Code Available (3191)
Date of Event 12/19/2018
Type of Reportable Event Serious Injury
Event or Problem Description
Revision surgery - after speaking with the patient, the surgeon decided to exchange the 75 standard offset proximal body with a 85 lateral offset to creat more stability for the patient.
 
Additional Manufacturer Narrative
The reason for this revision surgery was to create more stability.The previous surgery and the surgery detailed in this investigation occurred 35 days apart.There is no information in this complaint about any patient injuries, activities, or accidents that may have contributed to the need for this revision surgery.There are no reported pre-existing patient health conditions.The healthcare professional indicated there was no delay in surgery and another suitable device was available for use.The revision surgery was completed as intended.The device was not made available to djo surgical for examination.A review of the implant device history records (dhr), shows that the reported component used in the previous surgery, when released for use, met design and manufacturing requirements.There were no non-conforming material reports (ncmrs) associated with the product that may have contributed to the reported event.The device was verified to have gone through an acceptable sterilization process and was within its expiration date at the time of use during the previous surgery.Customer complaint history of the reported device showed no present trends or on-going issues that are in need of review.The root cause of this complaint was a revision surgery to create more stability.There were no findings during this investigation that indicate that the reported device was defective.There are multiple factors that may contribute to an event that are outside of the control of djo surgical.Inventory containment is not required as there are no indications of a product or process issue affecting implant safety or effectiveness.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EXPRT REVISION HIP
Common Device Name
EXPRT REVISION HIP, STANDARD OFFSET PROXIMAL BODY, 75MM
Manufacturer (Section D)
ENCORE MEDICAL L.P.
9800 metric blvd
austin TX 78758 5445
MDR Report Key8244992
Report Number1644408-2019-00013
Device Sequence Number2463528
Product Code KWZ
UDI-Device Identifier00190446153825
UDI-Public(01)00190446153825
Combination Product (Y/N)N
Initial Reporter StateMS
Initial Reporter CountryUS
PMA/510(K) Number
K161610
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Device Explanted Year2018
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 02/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/23/2024
Device Catalogue Number495-00-075
Device Lot Number541U1015
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 12/19/2018
Supplement Date Received by Manufacturer02/05/2019
Initial Report FDA Received Date01/14/2019
Supplement Report FDA Received Date02/15/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
400-03-364, LOT 869B1122; 400-03-364, LOT 869B1122
Outcome Attributed to Adverse Event Required Intervention;
Patient Age51 YR
-
-